HDL-boosting combination therapy complexes
   
   

A pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent.

 
Web www.patentalert.com

< Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease

< Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

> Method and compositions for the treatment and prevention of pain and inflammation

> Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders
~ 00180